CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

New Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer

“The Decipher Prostate test’s ability to help guide treatment for [...]

By |2024-09-15T13:38:47+00:00September 15, 2024|3rd Party Medical Device Industry News|Comments Off on New Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer

Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and Cancer

“This analytical validation study strongly complements EsoGuard’s extensive peer-reviewed, published [...]

By |2024-08-20T13:50:04+00:00August 20, 2024|3rd Party Medical Device Industry News|Comments Off on Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and Cancer
Go to Top